Tenofovir-Associated Nephrotoxicity in Two HIV-Infected Adolescent Males
- 1 January 2009
- journal article
- case report
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 23 (1) , 1-4
- https://doi.org/10.1089/apc.2008.0106
Abstract
We report two cases of tenofovir (TDF)-associated nephrotoxicity in perinatally HIV-infected adolescents. The first case, a 16-year-old African American male with an absolute CD4+ cell count of 314 cells/mm3, presented with an abrupt rise in serum creatinine leading to irreversible renal failure while on TDF-containing highly active antiretroviral therapy (HAART). While the patient had evidence of underlying kidney disease, the timing of his renal failure indicates that TDF played a central role. The second case, a 16-year-old African-American male with an absolute CD4+ cell count of 895 cells/mm3, presented with rickets and hypophosphatemia while receiving TDF-based HAART. To our knowledge, these cases represent the first reports of TDF-associated irreversible renal failure and rickets in pediatric patients. We believe these cases highlight important and potentially irreversible side effects of this agent and emphasize the need for further studies of the renal safety of TDF in pediatric patients.Keywords
This publication has 22 references indexed in Scilit:
- Decreased Bone Mineral Density with Off-Label Use of Tenofovir in Children and Adolescents Infected with Human Immunodeficiency VirusThe Journal of Pediatrics, 2008
- INCREASED β-2 MICROGLOBULINURIA IN HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED CHILDREN AND ADOLESCENTS TREATED WITH TENOFOVIRThe Pediatric Infectious Disease Journal, 2007
- Adverse events experienced by three children taking tenofovir and didanosine in combinationHIV Medicine, 2007
- Effect of tenofovir on renal glomerular and tubular functionAIDS, 2007
- Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected ChildrenPublished by American Academy of Pediatrics (AAP) ,2006
- Urinaryβ2-Microglobulin as a Possible Sensitive Marker for Renal Injury Caused by Tenofovir Disoproxil FumarateAIDS Research and Human Retroviruses, 2006
- Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavirPediatric Nephrology, 2006
- Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapyHIV Medicine, 2006
- Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment—case report and review of literatureJournal of Infection, 2005
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004